Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review Article
  • Published:

Therapy Insight: clinical management of pregnant women with epilepsy

Nature Clinical Practice Neurology volume 2, pages 190–200 (2006)Cite this article

Abstract

In pregnant women with epilepsy who are being treated with antiepileptic drugs (AEDs), careful clinical management is vital because seizure frequency can change during pregnancy, and both seizure activity and AED treatment can have consequences for the developing fetus. Complications of epilepsy and AED treatment include stillbirths, prematurity, low birth weight, major and minor malformations, and cognitive delay later in life. Certain AEDs probably have more adverse effects than others; data from prospective studies indicate that phenobarbital and valproate are associated with significant increases in major malformations, and retrospective studies show lower verbal IQs and greater need for extra assistance in school for children whose mothers received valproate during pregnancy. Monitoring of AED levels and dosage adjustment are warranted throughout pregnancy, and vitamin K1 at a dose of 10 mg/day should be given in the last month, particularly when cytochrome P450 enzyme-inducing AEDs are being administered. In the postpartum period, breastfeeding is recommended; however, there is differential transfer of individual AEDs in breast milk, and the infant should be observed clinically. For all women of reproductive age, preconceptual counseling is important, and includes optimization of the AED regimen and advising the mother to take supplemental folic acid.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Foldvary-Schaefer N et al. (2004) Hormones and seizures. Cleve Clin J Med 71 (Suppl 2): S11–S18

    Article  Google Scholar 

  2. Pennell P (2005) Using current evidence in selecting antiepilepsy drugs for use during pregnancy. Epilepsy Curr 5: 45–51

    Article  Google Scholar 

  3. Hallak M et al. (1999) Fetal rat brain damage caused by maternal seizure activity: prevention by magnesium sulfate. Am J Obstet Gynecol 181: 828–834

    Article  CAS  Google Scholar 

  4. Adab N et al. (2004) The longer term outcome of children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 75: 1575–1583

    Article  CAS  Google Scholar 

  5. Nei M et al. (1998) A maternal complex partial seizure in labor can affect fetal heart rate. Neurology 51: 904–906

    Article  CAS  Google Scholar 

  6. Sahoo S and Klein P (2005) Maternal complex partial seizure associated with fetal distress. Arch Neurol 62: 1304–1305

    Article  Google Scholar 

  7. Vinten J et al. (2005) Neuropsychological effects of exposure to anticonvulsant medication in utero. Neurology 64: 949–954

    Article  CAS  Google Scholar 

  8. Speidel BD and Meadow SR (1972) Maternal epilepsy and abnormalities of the fetus and newborn. Lancet 2: 839–843

    Article  CAS  Google Scholar 

  9. Bjerkedal T and Bahna SL (1973) The course and outcome of pregnancy in women with epilepsy. Acta Obstet Gynecol Scand 52: 245–248

    Article  CAS  Google Scholar 

  10. Olafsson E et al. (1998) Pregnancies of women with epilepsy: a population-based study in Iceland. Epilepsia 39: 887–892

    Article  CAS  Google Scholar 

  11. Monson RR et al. (1973) Diphenylhydantoin and selected congenital malformations. N Engl J Med 289: 1049–1052

    Article  CAS  Google Scholar 

  12. Hanson JW et al. (1976) Risks to the offspring of women treated with hydantoin anticonvulsants, with emphasis on the fetal hydantoin syndrome. J Pediatr 89: 662–668

    Article  CAS  Google Scholar 

  13. Holmes LB et al. (2001) The teratogenicity of anticonvulsant drugs. N Engl J Med 344: 1132–1138

    Article  CAS  Google Scholar 

  14. Lindhout D et al. (1992) Antiepileptic drugs and teratogenesis in two consecutive cohorts: changes in prescription policy paralleled by changes in pattern of malformations. Neurology 42 (Suppl 5): S94–S110

    Google Scholar 

  15. Nakane Y (1979) Congenital malformation among infants of epileptic mothers treated during pregnancy—the report of a collaborative study group in Japan. Folia Psychiatr Neurol Jpn 33: 363–369

    CAS  PubMed  Google Scholar 

  16. Artama M et al. (2005) Antiepileptic drug use of women with epilepsy and congenital malformations in offspring. Neurology 64: 1874–1878

    Article  CAS  Google Scholar 

  17. Holmes LB et al. (2004) The AED (antiepileptic drug) pregnancy registry: a 6-year experience. Arch Neurol 61: 673–678

    Article  Google Scholar 

  18. Wyszynski DF et al. (2005) Increased rate of major malformations in offspring exposed to valproate during pregnancy. Neurology 64: 961–965

    Article  CAS  Google Scholar 

  19. Vajda FJ et al. (2003) The Australian registry of anti-epileptic drugs in pregnancy: experience after 30 months. J Clin Neurosci 10: 543–549

    Article  CAS  Google Scholar 

  20. Vajda FJ et al. (2004) Critical relationship between sodium valproate dose and human teratogenicity: results of the Australian register of anti-epileptic drugs in pregnancy. J Clin Neurosci 11: 854–858

    Article  CAS  Google Scholar 

  21. Vajda F et al. (2004) Australian pregnancy registry of women taking antiepileptic drugs. Epilepsia 45: 1466

    Article  Google Scholar 

  22. Vajda FJ and Eadie MJ (2005) Maternal valproate dosage and foetal malformations. Acta Neurol Scand 112: 137–143

    Article  CAS  Google Scholar 

  23. Morrow JI et al. (2005) Malformation risks of anti-epileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 77: 193–198

    Article  Google Scholar 

  24. Russell AJ et al. (2004) U.K. epilepsy and pregnancy group. Epilepsia 45: 1467

    Article  Google Scholar 

  25. Tomson T et al. (2004) EURAP: an international registry of antiepileptic drugs and pregnancy. Epilepsia 45: 1463–1464

    Article  Google Scholar 

  26. Cunnington M and Tennis P (2005) Lamotrigine and the risk of malformations in pregnancy. Neurology 64: 955–960

    Article  CAS  Google Scholar 

  27. Matalon S et al. (2002) The teratogenic effect of carbamazepine: a meta-analysis of 1255 exposures. Reprod Toxicol 16: 9–17

    Article  CAS  Google Scholar 

  28. Rosa FW (1991) Spina bifida in infants of women treated with carbamazepine during pregnancy. N Engl J Med 324: 674–677

    Article  CAS  Google Scholar 

  29. Hernandez-Diaz S et al. (2001) Neural tube defects in relation to use of folic acid antagonists during pregnancy. Am J Epidemiol 153: 961–968

    Article  CAS  Google Scholar 

  30. Montouris G (2005) Safety of the newer antiepileptic drug oxcarbazepine during pregnancy. Curr Med Res Opin 21: 693–701

    Article  CAS  Google Scholar 

  31. Montouris G (2003) Gabapentin exposure in human pregnancy: results from the Gabapentin Pregnancy Registry. Epilepsy Behav 4: 310–317

    Article  Google Scholar 

  32. Long L (2003) Levetiracetam monotherapy during pregnancy: a case series. Epilepsy Behav 4: 447–448

    Article  Google Scholar 

  33. Kondo T et al. (1996) Preliminary report on teratogenic effects of zonisamide in the offspring of treated women with epilepsy. Epilepsia 37: 1242–1244

    Article  CAS  Google Scholar 

  34. Pennell PB (2003) The importance of monotherapy in pregnancy. Neurology 60 (Suppl 4): S31–S38

    Article  CAS  Google Scholar 

  35. Holmes LB et al. (2005) The correlation of deficits in IQ with midface and digit hypoplasia in children exposed in utero to anticonvulsant drugs. J Pediatr 146: 118–122

    Article  CAS  Google Scholar 

  36. Gaily E et al. (2004) Normal intelligence in children with prenatal exposure to carbamazepine. Neurology 62: 28–32

    Article  CAS  Google Scholar 

  37. Adab N et al. (2001) Additional educational needs in children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 70: 15–21

    Article  CAS  Google Scholar 

  38. Reinisch JM et al. (1995) In utero exposure to phenobarbital and intelligence deficits in adult men. JAMA 274: 1518–1525

    Article  CAS  Google Scholar 

  39. Eriksson K et al. (2005) Children exposed to valproate in utero—population based evaluation of risks and confounding factors for long-term neurocognitive development. Epilepsy Res 65: 189–200

    Article  CAS  Google Scholar 

  40. Meador K et al. (2005) Differential and dose dependent effects of in utero antiepileptic drugs [abstract #427]. Neurology 64 (Suppl 1): aS62.002

    Google Scholar 

  41. Bahado-Singh RO and Sutton-Riley J (2004) Biochemical screening for congenital defects. Obstet Gynecol Clin North Am 31: 857–872

    Article  Google Scholar 

  42. Fong KW et al. (2004) Detection of fetal structural abnormalities with US during early pregnancy. Radiographics 24: 157–174

    Article  Google Scholar 

  43. Pennell PB et al. (2004) The impact of pregnancy and childbirth on the metabolism of lamotrigine. Neurology 62: 292–295

    Article  CAS  Google Scholar 

  44. Petrenaite V et al. (2005) Individual changes in lamotrigine plasma concentrations during pregnancy. Epilepsy Res 65: 185–188

    Article  CAS  Google Scholar 

  45. Choulika S et al. (2004) Is antenatal vitamin K prophylaxis needed for pregnant women taking anticonvulsants? Am J Obstet Gynecol 190: 882–883

    Article  CAS  Google Scholar 

  46. Kaaja E et al. (2002) Enzyme-inducing antiepileptic drugs in pregnancy and the risk of bleeding in the neonate. Neurology 58: 549–553

    Article  CAS  Google Scholar 

  47. Astedt B (1995) Antenatal drugs affecting vitamin K status of the fetus and the newborn. Semin Thromb Hemost 21: 364–370

    Article  CAS  Google Scholar 

  48. [No authors listed] (1998) Practice parameter: management issues for women with epilepsy (summary statement). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Epilepsia 39: 1226–1231

  49. Pennell PB (2003) Antiepileptic drug pharmacokinetics during pregnancy and lactation. Neurology 61 (Suppl 2): S35–S42

    Article  CAS  Google Scholar 

  50. Liporace J et al. (2004) Concerns regarding lamotrigine and breast-feeding. Epilepsy Behav 5: 102–105

    Article  Google Scholar 

  51. Johannessen SI et al. (2005) Levetiracetam concentrations in serum and in breast milk at birth and during lactation. Epilepsia 46: 775–777

    Article  CAS  Google Scholar 

  52. Ohman I et al. (2002) Topiramate kinetics during delivery, lactation, and in the neonate: preliminary observations. Epilepsia 43: 1157–1160

    Article  Google Scholar 

  53. Ohman I et al. (2005) Pharmacokinetics of gabapentin during delivery, in the neonatal period, and lactation: does a fetal accumulation occur during pregnancy? Epilepsia 46: 1621–1624

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. an assistant professor of clinical neurology at Columbia University College of Physicians and Surgeons, New York, NY, USA

    Alison M Pack

Authors
  1. Alison M Pack
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alison M Pack.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pack, A. Therapy Insight: clinical management of pregnant women with epilepsy. Nat Rev Neurol 2, 190–200 (2006). https://doi.org/10.1038/ncpneuro0153

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneuro0153

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing